COVID-19: The CIDRAP Viewpoint Part 3: Smart Testing for COVID-19 Virus and Antibodies [open pdf - 0B]
From the Introduction: "Testing for SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2]--the virus that causes COVID-19 [coronavirus disease 2019]--is one part of the complex system required to address the pandemic. Testing is essential to confirm infection in cases and contacts, guide patient care, inform our understanding of transmission dynamics, prepare the health system for case surges, and inform the level of economic activity consistent with public health goals for limiting SARS-CoV-2 transmission. Technology to conduct molecular, antigen, and serology tests is now available, and additional technologies will be made available soon. The requirements for SARS-CoV-2 testing are unprecedented in both their urgency and the need for scalability, which present both technical and policy challenges. Current plans for clinical and public health laboratory testing do not sufficiently address the infrastructure needed to perform such tests. Critical guidance and coordination at the federal level is needed to meet the SARS-CoV-2 testing demand."
2020 Regents of the University of Minnesota
Center for Infectious Disease Research & Policy (CIDRAP): https://www.cidrap.umn.edu/